bipolar depressive disorder
Conditions
Interventions
20:Lithium, Sodium valproate, Lamotrigine, MECT, Sertraline, Citalopram, Escitalopram, venlafaxine, Quetiapine, Olanzapine, Risperidone, sulpiride
Sponsors
Guangzhou Scientific and Technological Bureau, Guangzhou Board of Health
Eligibility
Sex/Gender
All
Age
17 Years to 65 Years
Inclusion criteria
Inclusion criteria: Include the outpatients and inpatients met DSM-IV-TR bipolar depressive disorder and major depressive disorder; age of 17~65, both male and femal; Hamilton Depression Scale 17 item >=18; sign the informed consent.
Exclusion criteria
Exclusion criteria: Exclude the patients combinating with severe physical conditions and endocrinopathy; nonselective monamine oxidase inhibitors were used 1 month before included; long-term antipsychotics were used 2 month before included; thyroxine was used 3 month before included, and hornone was using when included; pregnant and lactating women, and who didn't take effective practise contraception.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Manic/hypomanic episode;General effects of CGI; | — |
Secondary
| Measure | Time frame |
|---|---|
| HAMA deduction rate;BPRS deduction rate; | — |
Countries
China
Contacts
Public ContactXu Guiyun
Outcome results
None listed